Literature DB >> 9110280

The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors.

R K Jain1.   

Abstract

To reach cancer cells in a tumor, a blood-borne therapeutic molecule or cell must make its way into the blood vessels of the tumor and across the vessel wall into the interstitium and finally migrate through the interstitium. Unfortunately, tumors often develop in ways that hinder each of these steps. Our research goals are to analyze each of these steps experimentally and theoretically and then integrate the resulting information in a unified theoretical framework. This paradigm of analysis and synthesis has allowed us to obtain a better understanding of physiologic barriers in solid tumors and to develop novel strategies to exploit and/or to overcome these barriers for improved cancer detection and treatment.

Entities:  

Mesh:

Year:  1997        PMID: 9110280     DOI: 10.3109/10739689709148314

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  35 in total

1.  Targeting microparticles to select tissue via radiation-induced upregulation of endothelial cell adhesion molecules.

Authors:  Mohammad F Kiani; Hong Yuan; Xin Chen; Lee Smith; M Waleed Gaber; Douglas J Goetz
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

Review 2.  Causes and effects of heterogeneous perfusion in tumors.

Authors:  R J Gillies; P A Schornack; T W Secomb; N Raghunand
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

Review 3.  Current methods for assaying angiogenesis in vitro and in vivo.

Authors:  Carolyn A Staton; Stephen M Stribbling; Simon Tazzyman; Russell Hughes; Nicola J Brown; Claire E Lewis
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

4.  A microfluidic system for investigation of extravascular transport and cellular uptake of drugs in tumors.

Authors:  Nelita T Elliott; Fan Yuan
Journal:  Biotechnol Bioeng       Date:  2011-12-26       Impact factor: 4.530

5.  Discovery of targeting ligands for breast cancer cells using the one-bead one-compound combinatorial method.

Authors:  Nianhuan Yao; Wenwu Xiao; Xiaobing Wang; Jan Marik; See Hyoung Park; Yoshikazu Takada; Kit S Lam
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

6.  Influence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly (methylmethacrylate) nanoparticles in experimental tumor models.

Authors:  J Lode; I Fichtner; J Kreuter; A Berndt; J E Diederichs; R Reszka
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

Review 7.  Antibody Drug Conjugates: Preclinical Considerations.

Authors:  Gadi G Bornstein
Journal:  AAPS J       Date:  2015-02-28       Impact factor: 4.009

8.  The interstitial distribution of macromolecules in rat tumours is influenced by the negatively charged matrix components.

Authors:  Helge Wiig; Christina C Gyenge; Olav Tenstad
Journal:  J Physiol       Date:  2005-06-30       Impact factor: 5.182

9.  Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human breast cancer and ovarian cancer xenografts.

Authors:  Beverly A Teicher; Krishna Menon; Enrique Alvarez; Chuan Shih; Margaret M Faul
Journal:  Invest New Drugs       Date:  2002-08       Impact factor: 3.850

10.  Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11.

Authors:  H Wildiers; G Guetens; G De Boeck; E Verbeken; B Landuyt; W Landuyt; E A de Bruijn; A T van Oosterom
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.